Make and explore Freedom of Information requests
Offensive? Unsuitable?
Requests for personal information and vexatious requests are not considered valid for FOI purposes (read more).
If you believe this request is not suitable, you can report it for attention by the site administrators
Report this requestAct on what you've learnt
Similar requests
HPV Vaccine Impact Assessment
To Department of Health by Steve Hinks 11 February 2012
Prevalence of ME (Myalgic Encephalomyelitis)
To Department of Health by Caron Ryalls 10 February 2012
Privacy mechanisms in CPRD
To Medicines and Healthcare products Regulatory Agency by Ross Anderson 17 March 2012
Linking CFS with the HPV vaccination
To Medicines and Healthcare products Regulatory Agency by Caron Ryalls 23 January 2012
Which ‘Controlled Drug’ is Sativex?
To Medicines and Healthcare products Regulatory Agency by Laurel Bush 16 February 2012
MHRA reports for Gardasil
To Medicines and Healthcare products Regulatory Agency by l costa 15 February 2012
paxil
To Medicines and Healthcare products Regulatory Agency by robin harring 21 February 2012
Gardasil adverse reactions in the UK
To Department of Health by Julie Jones 8 October 2010
PIL and SPC for Cervarix with all changes since 2007
To Medicines and Healthcare products Regulatory Agency by Caron Ryalls 23 January 2012
CFS/ME
Steve Hinks made this Freedom of Information request to Medicines and Healthcare products Regulatory Agency
This request has an unknown status. We're waiting for Steve Hinks to read a recent response and update the status.
From: Steve Hinks
13 December 2011
Dear Medicines and Healthcare products Regulatory Agency,
in the last 2 week your webpage reported that there was no link
between CFS and the HPV vaccine. In particular it mentioned a
specific newspaper report in daily newspapers concerning a girl
with 'coma like symptoms' and stated that this case is being
closely monitored and that specialists had been consulted and that
they had reported that there is no link between CFS and the HPV
vaccine.
Please name these specialists, their qualifications, experience and
knowledge of this specific case (by the way they were commenting on
the case of Lucy Hinks). No one from the MRHA has contacted her
family and it should be noted that the NHS who originally reported
this case made several mistakes in the Yellow Card submitted. Her
father has since submitted an accurate Yellow Card.
Yours faithfully,
Steve Hinks (Lucy's dad)
From: MHRA Central Enquiry Point
Medicines and Healthcare products Regulatory Agency
13 December 2011
Dear Enquirer,
Thank you for your enquiry to the Central Enquiry Point at the MHRA.
This automated response confirms that we have received your email and that
it will be dealt with as quickly as possible.
You can expect a reply from us within a few days for a straightforward
request, however where a more detailed response or contribution from a
specialist is required this is likely to take longer; we endeavour to
respond to all requests within the Department of Health’s target response
time of 20 working days. For further information about our service and how
we handle different types of request, please view the information
published at the ‘Central Enquiry Point’ section of our website at the
following link:
[1]http://www.mhra.gov.uk/Contactus/Central...
If you have not heard from us after 20 working days then please contact us
on 020 3080 6000.
Kind regards
Central Enquiry Point
Information Services
Medicines and Healthcare products Regulatory Agency
Please note this is an automated reply; please do not respond to this
message.
This email and any files transmitted with it are confidential. If you are
not the intended recipient, any reading, printing, storage, disclosure,
copying or any other action taken in respect of this email is prohibited
and may be unlawful.
If you are not the intended recipient, please notify the sender
immediately by using the reply function and then permanently delete what
you have received.Incoming and outgoing email messages are routinely
monitored for compliance with the Department of Healths policy on the use
of electronic communications.
For more information on the Department of Healths email policy, click
http://www.dh.gov.uk/DHTermsAndCondition...
show quoted sections
Communications via the GSi may be automatically logged, monitored and/or
recorded for legal purposes.
References
Visible links
1. http://www.mhra.gov.uk/Contactus/Central...
From: MHRA Central Enquiry Point
Medicines and Healthcare products Regulatory Agency
14 December 2011
Our Ref: FOI 11/484
Dear Mr Hinks,
RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000
Thank you for your enquiry which we received on 14 December 2011.
I confirm that your request is being handled under the Freedom of
Information Act and you should receive a reply within 20 working days
from our date of receipt.
If you need to contact us again about this request, please quote the
reference number above.
Yours Sincerely
Central Enquiry Point
Information Services
MHRA
151 Buckingham Palace Road
London
SW1W 9SZ
show quoted sections
From: MHRA Central Enquiry Point
Medicines and Healthcare products Regulatory Agency
11 January 2012
Dear Steve Hinks,
Thank you for your recent enquiry to the MHRA.
Attached is the response to your FOI request.
Please contact us again if you need further assistance with this, or any
other queries.
Kind Regards,
Central Enquiry Point
Information Services
Medicines and Healthcare products Regulatory Agency
Tel: 020 3080 6000
show quoted sections
From: Steve Hinks
11 January 2012
Dear MHRA Central Enquiry Point,
Please investigate again - I provide further information:
On 5 December 2011 K Darke reported on NHS Choices the following
comment:
There have been recent reports in the press regarding a 13-year-old
girl who has been in a 'waking' coma since having her third HPV
vaccination. The girl was reported to have chronic fatigue syndrome
(CFS).
The Medicines and Healthcare products Regulatory Agency (MHRA) has
kept this issue under close review and its advice, endorsed by
independent experts, is that the vaccine is not a cause of CFS.
See the MHRA website for a full report on the safety of HPV vaccine
www.mhra.gov.uk/Safetyinformation/DrugSa...
I don't know who K Darke is but I certainly believe he/she is not a
member of the public. I suspect he/she is an employee of the MRHA
or NHS.
I have at least one other witness that saw this web page and
reported it to me in writing.
Yours sincerely,
Steve Hinks
From: MHRA Central Enquiry Point
Medicines and Healthcare products Regulatory Agency
11 January 2012
Dear Enquirer,
Thank you for your enquiry to the MHRA. This automated response confirms
that we have received your email and that it will be dealt with as quickly
as possible.
You can expect a reply from us within a few days for a straightforward
request, however where a more detailed response or contribution from a
specialist is required this is likely to take longer; we endeavour to
respond to all requests within the Department of Health’s target response
time of 20 working days. Further information on how we handle different
requests can be found on our website at the link below:
[1]http://www.mhra.gov.uk/Contactus/Central...
The MHRA website contains a wealth of information which may assist with
your enquiry. Some of our popular pages are:
Clinical Trials:
[2]http://www.mhra.gov.uk/Howweregulate/Med...
      Â
Manufacturer’s and wholesale dealer’s licences:
[3]http://www.mhra.gov.uk/Howweregulate/Med...
Registration of medical devices, opticians and dental laboratories:
[4]http://www.mhra.gov.uk/Howweregulate/Dev...
Reporting a side effect to a medicine:
[5]http://www.mhra.gov.uk/Safetyinformation...
Does my product need a licence?:
[6]http://www.mhra.gov.uk/Howweregulate/Med...
If you have not heard from us after 20 working days then please contact us
on 020 3080 6000.
Coming soon: We will be conducting a survey of our Enquiry Point, seeking
your views on the service we provide and any enhancements you would like
to see. Click here for further information: [7]Central Enquiry Point.
Kind regards
Central Enquiry Point
Information Services
Medicines and Healthcare products Regulatory Agency
Please note this is an automated reply; please do not respond to this
message.
This email and any files transmitted with it are confidential. If you are
not the intended recipient, any reading, printing, storage, disclosure,
copying or any other action taken in respect of this email is prohibited
and may be unlawful.
If you are not the intended recipient, please notify the sender
immediately by using the reply function and then permanently delete what
you have received.Incoming and outgoing email messages are routinely
monitored for compliance with the Department of Healths policy on the use
of electronic communications.
For more information on the Department of Healths email policy, click
http://www.dh.gov.uk/DHTermsAndCondition...
show quoted sections
Communications via the GSi may be automatically logged, monitored and/or
recorded for legal purposes.
References
Visible links
1. http://www.mhra.gov.uk/Contactus/Central...
2. http://www.mhra.gov.uk/Howweregulate/Med...
3. http://www.mhra.gov.uk/Howweregulate/Med...
4. http://www.mhra.gov.uk/Howweregulate/Dev...
5. http://www.mhra.gov.uk/Safetyinformation...
6. http://www.mhra.gov.uk/Howweregulate/Med...
7. http://www.mhra.gov.uk/Contactus/Central...
From: MHRA Central Enquiry Point
Medicines and Healthcare products Regulatory Agency
19 January 2012
Dear Steve Hinks,
Thank you for your recent enquiry to the MHRA.
Attached is the response to the follow up query in relation to FOI 11/484.
<<FOI 11 484_2 19.01.12.doc>>
Please contact us again if you need further assistance with this, or any
other queries.
Kind Regards,
Central Enquiry Point
Information Services
Medicines and Healthcare products Regulatory Agency
Tel: 020 3080 6000
Coming soon: We will be conducting a survey of our Enquiry Point, seeking
your views on the service we provide and any enhancements you would like
to see. Click here for further information:
[1]www.mhra.gov.uk/Contactus/CentralEnquiryPoint/index.htmPoint.
show quoted sections
From: Steve Hinks
6 February 2012
Dear Medicines and Healthcare products Regulatory Agency,
Please pass this on to the person who conducts Freedom of
Information reviews.
I am writing to request an internal review of Medicines and
Healthcare products Regulatory Agency's handling of my FOI request
'CFS/ME'.
On the 13th December I submitted a request to the MHRA making
reference to a report on their webpage to my daughters case. It
stated "the MHRA has kept this issue under close review and its
advice, endorsed by independent experts, is that the vaccine is not
the cause of CFS. This is a safe vaccine". I requested the names of
the specialists (independent experts), their qualifications,
experience and knowledge of this specific case. I was advised "we
have no records of such a statement on our website". I provided
further information and was told "the report referred to by K Darke
within the correspondence is the two year safety review conducted
in July 2010". This again is not the report I was referring to
which definitely appeared on the MHRA web page and was witnessed by
at least one friend who wrote to me to inform me of its existence.
Although I was not able to prove otherwise I have now stumbled
across the exact same report on another Department of Health web
page at
www.immunisation.dh.gov.uk/cervical-canc....
This is definitely the report which also appeared on the MHRA web
page. I am seriously concerned that dishonesty and cheating is
going on within the DH and MHRA - I have already obtained evidence
that Professor David Salisbury has required the MHRA to have the
Cervarix EMC Medicine Guide firstly removed from the NHS Choices
website and then modified because he doesn't agree with it. This is
unethical. I thought these were supposed to be the manufacturers
medicine guides "approved" by the MHRA. It is clearly wrong that
the man in charge of immunisations in the UK and hell bent on a
high uptake of vaccine is allowed to dilute the safety rules. It is
already incredible that this man is able to lead a national
immunisation campaign which totally disregards these safety rules
denying parents and girls their right to make an informed choice.
I would expect that this matter is fully and thoroughly
investigated, appropriate actions put in place to correct matters
and controls to prevent re-occurence.
A full history of my FOI request and all correspondence is
available on the Internet at this address:
http://www.whatdotheyknow.com/request/cf...
Yours faithfully,
Steve Hinks
From: MHRA Central Enquiry Point
Medicines and Healthcare products Regulatory Agency
6 February 2012
Dear Enquirer,
Thank you for your enquiry to the MHRA. This automated response confirms
that we have received your email and that it will be dealt with as quickly
as possible.
You can expect a reply from us within a few days for a straightforward
request, however where a more detailed response or contribution from a
specialist is required this is likely to take longer; we endeavour to
respond to all requests within the Department of Health’s target response
time of 20 working days. Further information on how we handle different
requests can be found on our website at the link below:
[1]http://www.mhra.gov.uk/Contactus/Central...
The MHRA website contains a wealth of information which may assist with
your enquiry. Some of our popular pages are:
Clinical Trials of medicines:
[2]http://www.mhra.gov.uk/Howweregulate/Med...
Clinical Trials of medical devices:
[3]http://www.mhra.gov.uk/Howweregulate/Dev...
Manufacturer’s and wholesale dealer’s licences:
[4]http://www.mhra.gov.uk/Howweregulate/Med...
Registration of medical devices, opticians and dental laboratories:
[5]http://www.mhra.gov.uk/Howweregulate/Dev...
Reporting a side effect to a medicine:
[6]http://www.mhra.gov.uk/Safetyinformation...
Reporting an adverse incident involving a medical device:
[7]http://www.mhra.gov.uk/Safetyinformation...
Does my product need a licence?:
[8]http://www.mhra.gov.uk/Howweregulate/Med...
Regulation of medical devices:
[9]http://www.mhra.gov.uk/Howweregulate/Dev...
If you have not heard from us after 20 working days then please contact us
on 020 3080 6000.
If you'd like to give us your views about the service provided by the
Central Enquiry Point, then please take part in our short survey by
following the link below. Your views are very important to us and will
shape how we develop the service over the coming months.
[10]https://www.surveymonkey.com/s/7TV3BSM
Kind regards
Central Enquiry Point
Information Services
Medicines and Healthcare products Regulatory Agency
Please note this is an automated reply; please do not respond to this
message.
This email and any files transmitted with it are confidential. If you are
not the intended recipient, any reading, printing, storage, disclosure,
copying or any other action taken in respect of this email is prohibited
and may be unlawful.
If you are not the intended recipient, please notify the sender
immediately by using the reply function and then permanently delete what
you have received.Incoming and outgoing email messages are routinely
monitored for compliance with the Department of Healths policy on the use
of electronic communications.
For more information on the Department of Healths email policy, click
http://www.dh.gov.uk/DHTermsAndCondition...
show quoted sections
Communications via the GSi may be automatically logged, monitored and/or
recorded for legal purposes.
References
Visible links
1. http://www.mhra.gov.uk/Contactus/Central...
2. http://www.mhra.gov.uk/Howweregulate/Med...
3. http://www.mhra.gov.uk/Howweregulate/Dev...
4. http://www.mhra.gov.uk/Howweregulate/Med...
5. http://www.mhra.gov.uk/Howweregulate/Dev...
6. http://www.mhra.gov.uk/Safetyinformation...
7. http://www.mhra.gov.uk/Safetyinformation...
8. http://www.mhra.gov.uk/Howweregulate/Med...
9. http://www.mhra.gov.uk/Howweregulate/Dev...
10. https://www.surveymonkey.com/s/7TV3BSM
From: Jones, Sue
Medicines and Healthcare products Regulatory Agency
29 February 2012
Dear Mr Hinks
Further to your request of 6th February for a review of your Freedom of
Information Act (FOIA) request number 11-484, this review has now been
completed and I attach a full report.
Yours sincerely
Sue Jones
MHRA Corporate, Policy & Government
151 Buckingham Palace Road
London SW1W 9SZ
Please do not print this message unless you have to
This email and any files transmitted with it are confidential. If you are
not the intended recipient, any reading, printing, storage, disclosure,
copying or any other action taken in respect of this email is prohibited
and may be unlawful.
If you are not the intended recipient, please notify the sender
immediately by using the reply function and then permanently delete what
you have received.Incoming and outgoing email messages are routinely
monitored for compliance with the Department of Healths policy on the use
of electronic communications.
For more information on the Department of Healths email policy, click
http://www.dh.gov.uk/DHTermsAndCondition...
show quoted sections
Communications via the GSi may be automatically logged, monitored and/or
recorded for legal purposes.
Things to do with this request
- Add an annotation (to help the requester or others)
- Download a zip file of all correspondence
Steve Hinks left an annotation ( 6 February 2012)
www.immunisation.dh.gov/ (followed by) cervical-cancer-jabs-coma-coverage-should-not-cause-concern/
Link to this